APA (7th ed.) Citation

Lin, S., Green, H. D., Hendy, P., Heerasing, N. M., Chanchlani, N., Hamilton, B., . . . Tyrrell, J. (2020). Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment. Journal of Crohn's & Colitis, 14(12), 1653. https://doi.org/10.1093/ecco-jcc/jjaa104

Chicago Style (17th ed.) Citation

Lin, Simeng, et al. "Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment." Journal of Crohn's & Colitis 14, no. 12 (2020): 1653. https://doi.org/10.1093/ecco-jcc/jjaa104.

MLA (9th ed.) Citation

Lin, Simeng, et al. "Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment." Journal of Crohn's & Colitis, vol. 14, no. 12, 2020, p. 1653, https://doi.org/10.1093/ecco-jcc/jjaa104.